Objective: The orbital periosteum is considered to be a barrier to tumor spread; however, it is difficult to evaluate microscopic tumor spread during surgery. This study aimed to assess the impact of pathological status in orbital preservation surgery. Methods: We retrospectively analyzed the 3-year local control rate and treatment outcomes of patients with malignant tumors invading the orbit who were treated between 2006 and 2012. Results: In total, 27 patients were reviewed over a median follow-up period of 36 months. Pathologically, 19 had carcinomas and 8 had sarcomas. Treatment was by orbital exenteration in 6 patients and orbital preservation surgery in 21 patients. After orbital preservation surgery, poorer 3-year local control rates were significantly associated with positive surgical margins (negative vs. positive: 91% vs. 41%, P = 0.040) and microscopic orbital periosteum invasion (negative vs. positive: 90% vs. 39%, P = 0.010). These factors were independent risk factors in multivariate analysis. The locations of the positive margin were most common at the horizontal and vertical margins of the orbital periosteum and the posterior margin of the orbital apex. Moreover, in 24% of patients, invasion evaluation by preoperative imaging study was underestimated compared with postoperative microscopic evaluation. Conclusions: The positive surgical margin and microscopic orbital periosteum invasion were the risk factors of orbital recurrence. It is difficult to determine the indications for orbital preservation surgery by preoperative imaging studies because of the unpredictable accurate pathological status before surgery and the limitations of preoperative imaging evaluation.
Introduction
Malignant tumors that invade the orbit are divided into two categories: extraorbital tumors and intraorbital tumors. Tumors of the nasal cavity or paranasal sinuses are classified as extraorbital tumors, while those of the eyelid, lacrimal gland or lacrimal sac are classified as intraorbital tumors. Of these, malignant maxillary sinus tumors are the most common, with 60-80% invading the orbit (1) . When treating these, preservation of the orbital contents remains a major concern. However, because of the general low incidence of intraorbital tumors, pathological diversity and the complex anatomy of the orbit, there are no clear indications for orbital preservation surgery (OPS).
The two main points of contention with OPS are oncological safety and the functional outcome after surgery. In general, the invasion of the orbital apex, extraocular muscles, bulbar conjunctiva, eyelid or sclera has been considered indications for orbital exenteration (1, 2) . Despite this, if the orbital periosteum has not been penetrated by the disease, it may be possible to preserve the orbit (3) , and in most cases, it appears that the orbit can be preserved without decreasing oncological control (1, 2, 4, 5) . However, although the orbital periosteum is known to be a barrier to tumor spread, it can be difficult to precisely evaluate tumor invasion of orbital periosteum (2, (4) (5) (6) . Consequently, the indications for OPS remain controversial. Moreover, various adverse effects are possible after OPS, including diplopia, lid ectropion, keratitis and loss of visual acuity, with risk factors for decreased orbital function being large resection of the orbital floor, resection of the eyelid and postoperative radiotherapy (2, 7) .
This study aimed to clarify the impact of pathological status (i.e. surgical margin and microscopic orbital periosteum invasion) in OPS.
Patients and methods

Study population
From January 2006 to December 2012, definitive treatment was performed on 37 patients with malignant tumors invading the orbit at the National Cancer Center Hospital of Japan. Of these 37 patients, 10 patients underwent super-selective intra-arterial chemotherapy with concomitant radiotherapy (RADPLAT) or concurrent chemoradiotherapy. These 10 patients were excluded from the analysis. The remaining 27 surgically treated patients were considered to be eligible for this retrospective analysis. The patient characteristics are shown in Table 1 . Ocular adnexa tumors, such as eyelid, lacrimal sac and nasolacrimal duct tumors, were included in this analysis because these tumors were located outside the orbital periosteum. Pathologically, there were 19 carcinomas and 8 sarcomas. We used the 2002 version of the World Health Organization criteria for histologic classification. The tumors were divided into three categories according to commonly accepted malignant potential; high-grade, intermediate-grade and low-grade. High-grade was defined as squamous cell carcinoma (SCC), high-grade transitional cell carcinoma, solid-type adenoid cystic carcinoma, high-grade adenocarcinoma and sarcomas (rhabdomyosarcoma, Ewing's sarcoma and grade 2 chondrosarcoma). Intermediate-grade was defined as cribriform-type adenoid cystic carcinoma. Low-grade was defined as low-grade adenocarcinoma and low-grade transitional cell carcinoma.
All patients had been previously untreated, and none had distant metastasis. However, neck metastasis was detected in four patients.
Preoperative classification of orbital invasion and management of orbital periosteum
As a preoperative evaluation, patterns of orbital invasion were divided into three types: type I, orbital invasion without orbital periosteum involvement; type II, orbital invasion with orbital periosteum involvement and type III, orbital fat invasion beyond the orbital periosteum (Fig. 1 ). There were 15, 4 and 8 cases, respectively. The extent of invasion was evaluated by preoperative imaging studies. The difference between type II and type I was determined by the presence or absence, respectively, of enhanced orbital periosteum by imaging studies. If the intra-orbit lesion had an irregular margin, was convex shape and invaded to extraocular muscles, we defined as type III.
As an intraoperative evaluation, we used frozen section evaluations to identify tumor localization and achieve complete surgical resection. We confirmed margin-negative resection during the surgery. The location of the frozen section biopsy was the closest point of surgical margin. Intraoperatively, tumors that were mildly adherent to the orbital periosteum, which could be easily detached with a surgical knife, were defined as negative macroscopic periosteum invasion, whereas tumors that were strongly adherent to the orbital periosteum and could not be detached with a surgical knife were defined as positive macroscopic periosteum invasion. In cases of macroscopic orbital periosteum invasion, we always resect the periosteum and evaluate the horizontal margin using frozen section evaluation. For all cases requiring resection of the orbital periosteum, we performed reconstruction using deep fascia from the thigh.
Treatment strategy
In our institution, the indications for orbital exenteration were as follows: (i) Bony destruction of the orbital apex or (ii) large orbital fat invasion. The orbit contents were preserved in other cases, such as invasion to the orbital periosteum or when there was small fat invasion. Induction chemotherapy was performed for chemo-radiosensitive sarcomas, such as rhabdomyosarcoma (VAC regimen: vincristine, actinomycin-D, and cyclophosphamide) or Ewing's sarcomas (VDC-IE regimen: vincristine, doxorubicin, and cyclophosphamide/ifosfamide and etoposide). In principle, we performed complete resection after induction chemotherapy, based on the initial imaging studies.
The operative procedures are summarized in Fig. 2 . Of the eight patients with type III invasion, six underwent orbital exenteration. The remaining 21 patients underwent OPS. In addition, two of the patients with limited type III invasion, four patients with type II invasion and two of type I patients with macroscopic orbital periosteum invasion underwent orbital periosteum resection and reconstruction. To ensure complete resection, we adopted skull base surgery, total maxillectomy or partial maxillectomy, depending on the tumor involvement. Neck dissection was performed in 16 patients: 4 for node-positive neck and 12 for microvascular anastomosis in free flap reconstruction.
Following surgery, all resected specimens were evaluated by the treating surgeons and a pathologist (M.T. in all cases), and we performed microscopic margin surveillance. Surgeons and pathologists were involved in making and discussing all histologic sections for surveillance. We classified microscopic surgical margins as either positive, i.e. tumor cut-through; close or negative margin. Close and negative margins were defined as a distance of clear pathologic margin of <5 mm and ≥5 mm, respectively.
Whenever possible, postoperative radiotherapy was performed for patients with positive surgical margins or chemo-radiosensitive sarcomas. In cases with close surgical margins or high-grade histopathology, postoperative radiotherapy was considered on a case by case basis. Postoperative radiotherapy was performed in 14 cases. Patients received 70 Gy in 2 Gy fractions for margin-positive carcinomas or 50.4 Gy in 1.8 Gy fractions for margin-positive chemoradiosensitive sarcomas. Clinical target volume was decided based on preoperative radiological images and surgical, and pathological findings. Nine patients received intensity-modulated radiation therapy (IMRT), and five patients received three-dimensional conformal radiation therapy. However, five patients with margin-positive resections did not receive postoperative radiotherapy because three had pathologically radio-resistant slow-glowing tumors and two had been irradiated for a previous cancer.
The study was approved by our institutional ethics committee (2010-77) and was conducted in accordance with the Declaration of Helsinki.
Statistical analysis
We retrospectively analyzed the recurrence pattern, risk factors for local recurrence, 3-year local control rate (LCR), overall survival (OS) and orbital function after surgery. The definition of local control was the arrest of tumor growth at the primary site. LCR and OS were calculated using the Kaplan-Meier method, and differences were analyzed using log-rank tests and Cox's proportional hazard model. The chi-squared test was used to evaluate differences between two groups. For all analyses, a P value of <0.05 was considered statistically significant. Analyses were conducted using StatMate Version 2 (GraphPad, La Jolla, CA, USA).
Results
Overall outcome
Of the six patients treated with orbital exenteration, three underwent pathological complete resection, but the remaining three patients underwent gross total resection and had microscopic evidence of residual tumor. Recurrence occurred in two patients (one orbital recurrence, one distant recurrence), and salvage treatments were difficult for these cases. Among the six patients treated with orbital exenteration, the 3-year LCR and the OS were 80% and 50%, respectively.
By contrast, of the 21 patients treated by OPS, 11 underwent pathological complete resection; however, the remaining 10 patients were detected to have microscopic residual tumor on postoperative margin surveillance. Of the 11 patients who underwent complete resection, local and distal recurrences were detected in two patients (one intraorbital recurrence, one extraorbital recurrence) and two patients, respectively. On the other hand, local recurrence was detected in 7 of the 10 patients with microscopic residual tumors (five intraorbital recurrences, two extraorbital recurrences), and the remaining three had distant or neck recurrences. Again, salvage treatments for orbital recurrences were difficult, with only two cases (33%) salvaged by orbital exenteration. The 3-year LCR and OS were 68% and 57%, respectively, for the 21 patients treated with OPS. Although patients treated by OPS had poorer 3-year LCRs compared with the patients treated by orbital exenteration, the difference was not statistically significant (Fig. 3) . 
Risk factors for local recurrence
In univariate analysis, factors significantly associated with poorer 3-year LCR were a positive surgical margin (negative vs. positive: 91% vs. 41%, P = 0.040) and microscopic orbital periosteum invasion (negative vs. positive: 90% vs. 39%, P = 0.010). Poorer 3-year LCRs were seen with non-SCC pathological types, orbital periosteum invasion by preoperative evaluation (type II/III), intraoperative macroscopic periosteum invasion, large primary tumor and postoperative irradiation, but these results were not statistically significant (Table 2) . In multivariate analysis, both a positive surgical margin and microscopic orbital periosteum invasion were independent risk factors of local recurrence (Table 3) .
Details of the invasion pattern and outcome
Details of the invasion patterns, margin statuses, positive margin locations and recurrence patterns in patients undergoing OPS are shown in Table 4 . Of the 21 patients treated by OPS, microscopically 10 had positive margins and 4 had close margins. The horizontal or vertical margin of the orbital periosteum, as well as the posterior margin of the orbital apex, was the most predominant locations. Consequently, intraorbital recurrence was detected in six patients. Moreover, five patients (24%) had underestimated tumor invasion by preoperative imaging study evaluation when compared with the postoperative microscopic evaluation. In particular, even though the tumor could be detached from the orbital periosteum using a surgical knife, microscopically residual tumor existed in some cases. Microscopically, 33% of patients with macroscopic invasion had fat invasion and 15% with macroscopic invasion had invasion to the orbital periosteum. All these patients, in whom we Figure 3 . Survival curves for local control and overall survival. The orbital exenteration group is displayed as an dotted line, whereas the orbital preservation surgery group is displayed as a solid line. These results were not statistically significant. Abbreviations: OPS, orbital preservation surgery; LCR, local control rate. 
Orbital function after OPS
After OPS, 13 patients (62%) retained normal orbital function without recurrence, but three (14%) retained severe diplopia and five (24%) developed blindness. Patients with severe diplopia needed an eyepatch to avoid a double vision. Cases with exposure of the extraocular muscle during surgery were significantly more likely to retain severe diplopia than cases without extraocular muscle exposure (60% vs. 0%, P = 0.0089). However, free flap reconstruction did not affected the retention of severe diplopia (11% vs. 17%, P = 0.79) ( Table 5 ).
Discussion
Malignant tumors invading the orbit were classified by their origin into extra-and intraorbital tumors and were then classified by histopathological type. Consistent with the existing literature, we found that SCC was the most common pathological type in the extraorbital group (2, 8) . Regardless of the histopathological type, the greatest concern during treatment is the possibility of functional preservation of the orbital contents. Orbital exenteration was originally performed for all patients with bony orbital invasion, but by 1970, the concept of OPS had been reported (9, 10) . Despite the intervening time, the indications for this surgery remain controversial. Previous reports indicate that OPS could be done without decreasing oncological control when there was tumor invasion to the orbital periosteum, whereas other reports indicate that it may be possible in the presence of mild orbital fat invasion (11) . However, it is argued that the evaluation of intraoperative frozen sections was necessary to achieve a complete resection. In our analysis, we preserved the orbital contents in patients with small orbital fat invasion, but the 3-year LCR was consequently poor when OPS was compared with orbital exenteration. Moreover, in the OPS group, patients with positive surgical margins or microscopic orbital periosteum invasion had significantly worse 3-year LCRs. Most cases of positive or close surgical margins were located in the horizontal or vertical margin of the orbital periosteum or the posterior margin of the orbital apex.
Our results showed that complete surgical resection with accurate pre-or intraoperative estimation was essential for good outcomes from OPS. To achieve complete pathological resection, we used intraoperative frozen sections. However, it was difficult to completely evaluate tumor spread into orbital periosteum and orbital fat.
First, we observed two patterns of spread in the orbital periosteum: horizontal and vertical. Although the orbital periosteum was a barrier to tumor spread, microscopically it was only a thin membrane. Different from the bony skeleton, the embryologic origin of the craniofacial bone is the ectoderm, not the mesoderm, and ossification of this bone is intramembranous rather than endochondral (12) . These differences might increase the fragility of the orbital periosteum when compared with other periostea. Macroscopic tumor adhesion or membrane hypertrophy indicates microscopic orbital periosteum invasion. In our analysis, the wide horizontal spread suggests that tumors are surrounding the orbital contents and the severe vertical spread result in the complete penetration of the orbital periosteum (Fig. 4) . Moreover, preoperative or intraoperative evaluation of the orbital periosteum invasion was often underestimated as compared with microscopic evaluation. More specifically, microscopic tumor invasion was more aggressive than macroscopic invasion in some cases.
Second, there was no tumor barrier in the orbital fat. If tumor invaded beyond the orbital periosteum, microscopically it easily invaded in all directions. However, the evaluation of tumor spread pre-or intraoperatively was difficult, and 75% of patients with fat invasion (3/4) had intraorbital recurrence in this analysis. Given that salvage surgery for orbital recurrence was difficult, intraoperative decisions are needed regarding progress to orbital exenteration in patients with wide orbital periosteum invasion, severe orbital periosteal adhesions or small fat invasion.
Referring to the posterior margin of the orbital apex, in this analysis, we preserved the orbital contents to the cases without having a bony destruction of the orbital apex. Consequently, of the six patients with intraorbital recurrence, three had a residual tumor in the orbital apex microscopically. It was difficult to demonstrate whether the positive margin location was at the orbital periosteum cut end or at the bone cut end. Thus, we should pay more careful attention to the resection of the posterior margin of the orbital apex. Pathologically complete resectable tumors without invasion of the orbital periosteum or apex might be good indicators of OPS. However, it is difficult to determine the indications for OPS by the preoperative imaging studies because the pathological status could not be precisely evaluated before surgery. Moreover, preoperative imaging evaluation of invasion was often underestimated compared with postoperative microscopic evaluation. There were limitations for preoperative classification of orbital invasion. Before surgery, we need to carefully discuss with patients about the possibility of orbital preservation.
Induction chemotherapy was performed for eight chemo-sensitive sarcoma patients, which might have influenced the intraoperative evaluation. However, we performed complete radical resection based on the initial imaging studies. Intraoperative evaluation should be equal to preoperative evaluation, and this was observed in seven patients. However, one patient with progressive disease after induction chemotherapy had a periosteum invasion intraoperatively.
Orbital function after surgery is usually considered as important as oncological control. According to previous reports, about 60-70% of patients demonstrate adequate ocular function after OPS (8, 13) , which was comparable with our result of 61%. There have been reports that patients requiring a wide resection of the inferior orbital wall tend to retain severe diplopia and eye deviation after surgery (2,7), requiring the reconstruction of the inferior wall with a bonny flap. In this study, patients with the exposure of the extraocular muscle during surgery tended to retain severe diplopia. In these cases, it was difficult to achieve both oncological control and preserve orbital function. However, free flap reconstruction did not affect the retention of severe diplopia. Regardless of the resection size, adequate reconstruction by fascia or free flap might prevent sever diplopia.
Postoperative radiotherapy was performed in patients with positive surgical margins; therefore, 24% of patients (5/21) lost their eyesight. For posterior orbital lesions, the irradiated area typically included an optic nerve, despite using IMRT.
Super-selective intra-arterial chemotherapy with concomitant radiotherapy (RADPLAT) has been performed with success for patients with locally advanced maximally sinus carcinomas (14) and reportedly allows favorable oncological and functional outcomes (15) (16) (17) (18) . In a recent report, 24% of patients with advanced maxillary sinus SCC undergoing RADPLAT developed non-functioning orbits after treatment (13) . Although we achieved the same result (24%), because RADPLAT tends to be performed in more advanced cases, it cannot be compared directly. RADPLAT is primarily indicated for SCC, whereas surgical treatment may be possible for all histopathological types. Consequently, it is plausible that OPS could be developed as one of the important treatment strategies for malignancy with orbital invasion.
In conclusion, complete surgical resection was necessary when opting for OPS. Positive surgical margins and microscopic orbital periosteum invasion were significantly correlated with orbital recurrence. However, it is difficult to determine the indications for OPS by the preoperative imaging studies because both the pathological status could not be precisely evaluated before surgery, and there were limitations for preoperative classification of orbital invasion. Further research is needed to verify the findings of this study because this study had small sample size and included various pathological types.
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